scholarly journals Immunoconglutinin and Complement Studies in Congenital Nephrotic Syndrome and Nephritis of Henoch-Schonlein Purpura in Children

1971 ◽  
Vol 46 (250) ◽  
pp. 838-841 ◽  
Author(s):  
S. T. Shulman ◽  
T. M. Barratt ◽  
J. F. Soothill
2011 ◽  
Vol 15 (5) ◽  
pp. 749-753 ◽  
Author(s):  
Shinichiro Ohara ◽  
Yukihiko Kawasaki ◽  
Hiromi Matsuura ◽  
Tomoko Oikawa ◽  
Kazuhide Suyama ◽  
...  

Key Points Henoch-Schönlein purpura (HSP) is the most common form of vasculitis in children.It is a small-vessel vasculitis mediated by immunoglobulin A–containing immune complexes and characterized by nonthrombocytopenic purpura, abdominal pain, arthralgia, and renal disease.Diagnosis of HSP is clinical, and no laboratory tests are specific for HSP.Treatment is supportive. Patients with severe abdominal and joint pain may be treated with steroids.Steroids do not prevent renal disease in patients with HSP.Patients with nephritic or nephrotic syndrome have a much higher risk of developing chronic kidney disease and should be referred to a nephrologist.


Open Medicine ◽  
2008 ◽  
Vol 3 (4) ◽  
pp. 521-524
Author(s):  
Farkas Klaudia ◽  
Molnár Tamás ◽  
Nagy Ferenc ◽  
Tiszlavicz László ◽  
Németh István ◽  
...  

AbstractHenoch-Schönlein purpura (HSP) is a systemic small vessel vasculitis mainly affecting children. We report a case of a 49-year-old woman with severe gastrointestinal and renal involvement of HSP. Endoscopy revealed more characteristic findings in the terminal ileum than in the gastric antrum. Histological examinations of the biopsy samples from the ileum, antrum, skin and kidney confirmed the diagnosis of HSP. Parenteral corticosteroid therapy led to a rapid improvement of the gastrointestinal symptoms, but because of the excessive proteinuria intravenous cyclophosphamide therapy had to be introduced.


2019 ◽  
Vol 44 (4) ◽  
pp. 754-764 ◽  
Author(s):  
Jiaxing Tan ◽  
Yi Tang ◽  
Yicong Xu ◽  
Siyu Yan ◽  
Yuanyuan Xu ◽  
...  

Background: Henoch-Schönlein purpura nephritis (HSPN) is a common vasculitis involving the kidneys, with a lower incidence in adults. Meanwhile, nephrotic syndrome (NS) can appear in HSPN. However, the clinicopathological features and renal outcome of adult-onset HSPN presenting with NS (NS-HSPN) have not been well clarified. Methods: A total of 191 HSPN patients were prospectively analyzed and comparisons were made between NS-HSPN and non-NS-HSPN. Multivariate Cox regression analysis was carried out to find the unfavorable factors of renal outcome of NS-HSPN. Results: Among the 191 patients, 44 (23.0%) had NS-HSPN. Apart from edema and abdominal pain, patients with NS-HSPN tended to have lower levels of erythrocytes and hemoglobulin in blood as well as a greater number of erythrocytes in urine (p < 0.05). Mesangial proliferation was the most common pathological lesion in HSPN and the rates of crescent formation were significantly different, with 54.5% in NS-HSPN and 33.3% in non-NS-HSPN (p < 0.05). Notably, 18.2 and 4.8% of patients reached the composite endpoints in the NS-HSPN and non-NS-HSPN groups, respectively (p < 0.05), demonstrating that NS-HSPN patients were more likely to progress to end-stage renal disease and had a worse outcome. We also found that hypertension, estimated glomerular filtration rate (eGFR), cystatin, and tubular atrophy/interstitial fibrosis (HR > 1, p < 0.05) at onset were correlated with adverse outcome in NS-HSPN. Conclusion: NS-HSPN had more severe clinicopathological manifestations and poorer prognosis. The adverse predictors of NS-HSPN principally depend on clinicopathological presentation rather than on different therapies, and hypertension, eGFR, cystatin, and tubular atrophy/interstitial fibrosis can serve as independent risk factors in NS-HSPN.


Sign in / Sign up

Export Citation Format

Share Document